Cited by 77Antibiotic Resistance in BacteriaAntibiotic Use and ResistanceAntimicrobial Resistance in Staphylococcus

Using Combination Therapy to Thwart Drug Resistance

Hill, Jessica A, Cowen, Leah E·2015·Future Microbiology

Abstract

Drug combination therapy is a promising strategy to extend the lifespan of our antimicrobials. Drug combinations used in treatment must be carefully selected to minimize the evolution of resistance, either by carefully determining drug pairs that hinder the acquisition of resistance mechanisms, or by screening for combinations that inhibit growth and show reduced vulnerability to resistance. Modeling of interactions between drugs has provided intriguing insights into strategies for combination therapy deployment. Ultimately, more rigorous clinical trials need to be performed to evaluate the laboratory and modeling results and advance treatment options.

Integrity signals

Registry

Crossref · 10.2217/fmb.15.68

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hill, J. A., & Cowen, L. E.
Affiliations
University of Toronto (CA)
Venue
Future Microbiology
Published
2015-11
Volume
10
Issue
11
Pages
1719-1726
ISSN
  • 1746-0913 (ISSN-L)
  • 1746-0921
OpenAlex
W2173151789
Cited by
75
References
27
Citations by year
2026: 9 · 2025: 5 · 2024: 5 · 2023: 10 · 2022: 13 · 2021: 3 · 2020: 10 · 2019: 5 · 2018: 6 · 2017: 6 · 2016: 2 · 2015: 1
FWCI
2.07
Type
journal article
Language
en
Open access
closed
Locations
  • Future Microbiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Ontario Graduate Scholarship
  • Canada Research Chair in Microbial Genomics and Infectious Disease
  • Ministry of Research and Innovation Early Researcher Award
  • Natural Sciences & Engineering Research Council Discovery (355965)
  • Canadian Institutes of Health Research (MOP-119520, MOP-86452)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antibiotic Use and Resistance
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
Keywords
combination therapy, antimicrobial resistance, drug resistance mechanisms, drug interactions
MeSH terms
Anti-Infective Agents, Communicable Diseases, Drug Resistance, Drug Therapy, Combination, Humans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review